APA Citatie

Kitadate, A., Kobayashi, H., Abe, Y., Narita, K., Miura, D., Takeuchi, M., & Matsue, K. (2020). Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients. Haematologica.

Chicago Style citaat

Kitadate, Akihiro, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Daisuke Miura, Masami Takeuchi, en Kosei Matsue. "Pre-treatment CD38-positive Regulatory T Cells Affect the Durable Response to Daratumumab in Relapsed/refractory Multiple Myeloma Patients." Haematologica 2020.

MLA citatie

Kitadate, Akihiro, et al. "Pre-treatment CD38-positive Regulatory T Cells Affect the Durable Response to Daratumumab in Relapsed/refractory Multiple Myeloma Patients." Haematologica 2020.